Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Statins HMG-CoA reductase

As discussed above, obesity is associated with dyslipidemia, a condition where high levels of low-density lipoprotein cholesterol (LDL-C) is common. Elevated LDL-C is strongly associated with an elevated risk of coronary artery disease and for this reason a number of lipid-lowering therapies that target LDL-C have been developed. These include bile-acid sequestrants (BAS), statins (HMG-CoA reductase inhibitors), cholesterol absorption inhibitors, and fibrates. ... [Pg.133]

Also known as statins. HMG CoA reductase (Hydroxymethyl-Glutaryl Coenzyme A Reductase) inhibitors block the synthesis of cholesterol in liver by competitively inhibiting HMG CoA reductase activity, also cause depletion of critical intracellular pools of sterols and increased transcription of LDL receptors leading to enhanced removal from plasma of LDL cholesterol and LDL precursors. They also reduce hepatic synthesis of VLDL, increase plasma HDL. Reduction of LDL occurs over 4-6 weeks. [Pg.196]

Mulhaupt p Matter CM, Kwak BR, et al. Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells, Cardiovasc Res 2003 59 755-766,... [Pg.170]

Statins, HMG-CoA reductase inhibitors, form a class of hypolipidaemic drug used to lower cholesterol levels. Inhibition of HMG-CoA reductase stimulates LDL receptors, resulting in an increased clearance of LDL from the bloodstream, with a concomitant decrease in blood cholesterol levels. Drug effect is maximal after four to six weeks of use (see also Section 5.15). [Pg.117]

A 53-year-old male patient with elevated levels of low-density lipoprotein (LDL) cholesterol, signs of premature cholesterol gallstone disease and substantially elevated triglycerides visited his physician for a follow-up to check his current status. The patient had received various statin, HMG-CoA-reductase inhibitors therapies for the past 2 years. However, after blood work done at this follow-up visit, complications had still not subsided. This patient has similar problems as two of his siblings. Which of the following best explains this patients dyslipidemia ... [Pg.289]


See other pages where Statins HMG-CoA reductase is mentioned: [Pg.691]    [Pg.186]    [Pg.623]    [Pg.8]    [Pg.374]    [Pg.691]    [Pg.691]    [Pg.229]    [Pg.234]    [Pg.235]    [Pg.235]    [Pg.237]    [Pg.738]    [Pg.40]    [Pg.239]   


SEARCH



Discovery of HMG-CoA-Reductase Inhibitors (Statins)

HMG-CoA

HMG-CoA reductase

HMG-CoA reductase inhibitors statins)

Statine

Statins

© 2024 chempedia.info